Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2023
2022
2021
2020
Profitability Metrics
Gross Margin
0.00%
Operating Margin
27.84%
Net Margin
16.77%
Efficiency Metrics
Revenue per Expense Ratio
1.39
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
50.90%
Income Tax Rate
22.22%
EPS
0.6400000000
Balance Sheet Analysis
Current Ratio
10.97
Cash Ratio
4.47
Working Capital
$359.00M
Debt to Equity
3.09
Debt to Assets
72.06%
Equity Ratio
23.33%
Cash Flow Analysis
Operating Cash Flow Ratio
119.46%
Free Cash Flow Ratio
107.78%
CapEx to Revenue
11.68%
Dividends Paid
$116.00M
Stock Buybacks
$448.00M
Total Shareholder Returns
$564.00M
Cash Position Change
-5.85%
Key Takeaways (2023 FY)
Revenue declined by 6.7423230974633%, indicating potential market challenges
Increased dividend payments by 8.84%
Detailed Growth Metrics
Core Performance
Revenue
-6.74%
Net Income
-18.59%
EPS
-12.98%
Operating Income
-9.86%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
468.29%
Operating Cash Flow
-5.76%
Free Cash Flow
-5.83%
Balance Sheet Health
Assets
-2.18%
Debt
4.95%
Book Value per Share
-17.03%
Inventory
0.00%
Shareholder Returns
Dividends per Share
8.84%
Shares Outstanding
-6.53%
Long Term Trends
3Y Revenue/Share
18.92%
5Y Revenue/Share
-11.83%
3Y Dividend/Share
146.38%
5Y Dividend/Share
0.00%